Orexin Goes to BAT for Weight Control
Deficiency in the neuropeptide orexin is a cause of narcolepsy and also decreases appetite and food intake. Thus, it has been difficult to explain why narcoleptics or mice with orexin deficiency are at a greater risk for obesity. The answer now suggested by Sellayah et al. is that orexin enhances energy expenditure by directly stimulating the differentiation of brown adipose tissue (BAT). The authors show that mice lacking orexin exhibit greater weight gain than wild-type mice despite eating less and, when fed a high-fat diet, are unable to adjust their energy expenditure accordingly by promoting thermogenesis. Closer examination of the orexin-deficient mice reveals cellular defects in their brown adipocytes, most notably a decrease in mitochondrial content and triglyceride storage. In vitro, orexin induces preadipocyte cell lines and mesenchymal stem cells to differentiate into brown fat, and preadipocytes from mice lacking the orexin receptor OXR1 fail to differentiate in response to orexin. In a tantalizing experiment, the authors further show that injection of orexin into pregnant orexin-deficient mice ameliorates these cellular phenotypes in the offspring, which indicates that the defects may stem from early development. It remains to be determined whether this intervention will restore normal thermogenesis in these animals. For humans, these findings provide a glimpse of how a potential therapeutic intervention with orexin or OXR1 agonists might work at the cellular level to enhance energy expenditure and thus combat obesity. Sellayah, D., et al. (2011) . Cell Metab. 14, 478-490.
The Male Paunch Reflects Arrestin Development
Variation in the levels of energy expenditure contributes to obesity risk, which is known to have a significant genetic component. By conducting a genome-wide linkage scan in an Icelandic population, Patawari et al. now identify a risk locus for obesity that interestingly only impacts males, but not females. The locus contains a single gene, which encodes a previously uncharacterized arrestin called ARRDC3. The authors show that ARRDC3 expression in male omental adipose (intra-abdominal fat) goes up with increasing body mass index. To support a causal relationship, the authors turn to mice and establish that Arrdc3 deficiency promotes resistance to the obesity that comes with increasing age. Evidence suggests that this effect results from increased thermogenesis in both brown and white adipose tissue and is mediated at the molecular level by a direct interaction between ARRDC3 and b-adrenergic receptors, which limits their responsiveness to catecholamines. Hence, when ARRDC3 is high, energy expenditure is low. It remains to be determined what signals regulate ARRDC3's expression (and how to turn it down) and why men would be particularly sensitive to alterations in its levels or activity. Patwari, P., et al. (2011). Cell Metab. 14, 671-683. 
Placing Plac8 in Brown Fat Differentiation
Proteins that contribute to brown fat differentiation are compelling targets for the development of obesity treatment. Recent findings by Jimenez-Preitner et al. reveal a new regulator of brown fat differentiation and place its activity upstream of two well-known transcription factors, C/EBPb and Prdm16. Loss of this protein, called Plac8, leads to obesity and cold intolerance in mice, and close examination at the cellular level reveals altered lipid droplet morphology in brown adipocytes from the knockout mice. The authors show that overexpression of Plac8 in a brown fat cell line elevates C/EBPb and Prdm16 levels, promoting their differentiation. In the case of C/EBPb, this effect is mediated by a direct interaction between Plac8 and C/EBPb and its subsequent recruitment to the C/EBPb promoter to further stimulate its expression. This mechanism contrasts with a previously reported activity of Plac8, the binding of intracellular phagocytic granules in neutrophils to support their ability to kill bacteria. Future work may explore whether Plac8 has activities in adipocytes beyond the transcriptional role demonstrated by Jimenez-Preitner et al. and may reveal other targets that it regulates to promote the brown fat differentiation program. Jimenez-Preitner, M., et al. (2011). Cell Metab. 14, 658-670. Robert P. Kruger A genomic locus for obesity risk has been identified that only affects men.
Plac8 deficiency causes abnormal morphology of brown adipocytes.
